Skip to content

Acadia Leadership

Our leaders bring deep expertise in neurological disorders and rare diseases, dedicating their careers to advancing care for those most in need.

Executive Leadership Team
Board of Directors
Featured Perspectives

Executive Leadership Team

Chief Executive Officer

Catherine Owen Adams

Chief Commercial Officer

Thomas Garner

Chief Legal Officer and Secretary

Jennifer J. Rhodes

Chief Financial Officer

Mark Schneyer

Head of Research and Development

Elizabeth H.Z. Thompson, Ph.D.

Chief People Officer

Rob Ackles

Chief Information and Data Officer

Scott Cenci

Chief Business and Strategy Officer

Konstantina Katcheves

Board of Directors

Chairman

Stephen Biggar, M.D., Ph.D.

Director

Julian Baker

Director

Laura Brege

Director

James Daly

Director

Elizabeth Garofalo, M.D.

Director

Edmund Harrigan, M.D.

Director

Adora Ndu, Pharm.D., J.D.

Director

Catherine Owen Adams

Director

Daniel Soland

Featured Perspectives

From triumphs to challenges, we are promoting perspectives and driving discussion around the latest neuroscience topics. Read our insights and join the conversation.

October 30, 2024
Employee Spotlight

Meet the Trailblazers: Chirine Fiouzi

Acadia Pharmaceuticals’ building illuminated in purple lights during the evening, showcasing modern architecture and vibrant ambiance

October 9, 2024
Acadia Story

Putting Commitment into Action for Rett Syndrome Awareness Month

Colorful papel picado banners hanging from the ceiling with string lights, creating a festive atmosphere

October 7, 2024
Acadia Story

Embracing My Heritage: Reflections on Hispanic Heritage Month